Remove Funding Remove Layoffs Remove Report Remove Sales
article thumbnail

Glossier just laid off one-third of its corporate employees, mostly in tech

TechCrunch LA

“[W]e are shifting our technology strategy to leverage external partners for parts of our platform that we’re currently maintaining internally,” Weiss wrote in the email announcing the layoffs to staff. The tech team layoffs are notable for a beauty retailer that has often described itself as a technology company.

CTO Hire 197
article thumbnail

10 Cash-Flow Surprises That Could Kill Your Startup

Startup Professionals Musings

The sad truth is that cash flow surprises kill many startups, even though they should have been adequately funded to survive. Seasonal sales fluctuations eat cash. Fluctuating sales means more inventory is required to cover the ups and downs. Sales volumes are still ramping up while marketing expenses are at max.

Startup 114
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Is Your Startup Growing Too Quickly For Cash Flow?

Startup Professionals Musings

Seasonal sales fluctuations eat cash. Fluctuating sales means more inventory is required to cover the ups and downs. If you try to vary the number of employees to match, that costs even more cash for hiring, firing, and layoffs. Sales volumes are still ramping up while marketing expenses are at max.

Startup 64
article thumbnail

Biotech Roundup: Hellos, Goodbyes, “Cures” Delays And Trial News

Xconomy

” —Company funding news: Tesaro (NASDAQ: TSRO ) of Waltham, MA, said it took advantage of positive Phase 3 data to raise $409 million in a secondary stock sale…Protagonist Therapeutics, based in Milpitas, CA, has filed for a $75 million initial public offering. million in funding, according to a regulatory filing.

News 40
article thumbnail

Biotech Roundup: Moonshots, Pink Slips, Gilead, Brexit & More

Xconomy

But as Xconomy reported, details about the reorganization were scant, leaving open questions whether drug regulation actually needs to move faster. The technology was funded by the Department of Defense and comes from MIT’s Lincoln Lab. Buzzfeed reports that Katze is still drawing his UW salary, but his lab has been shut down.